Works matching IS 0344-5704 AND VI 72 AND IP 6 AND DT 2013

Results: 36

Flow cytometric chemosensitivity assay using JC1, a sensor of mitochondrial transmembrane potential, in acute leukemia.

Published in:

2013

By:

Yokosuka, Tomoko;
Goto, Hiroaki;
Fujii, Hisaki;
Naruto, Takuya;
Takeuchi, Masanobu;
Tanoshima, Reo;
Kato, Hiromi;
Yanagimachi, Masakatsu;
Kajiwara, Ryosuke;
Yokota, Shumpei

Publication type:

Journal Article

Evaluation of safety parameters and changes in serum concentration in liver transplant recipients treated with doxorubicin during the anhepatic period.

Published in:

2013

By:

Kobayashi, Shogo;
Wada, Hiroshi;
Hama, Naoki;
Akita, Hirofumi;
Kawamoto, Koichi;
Eguchi, Hidetoshi;
Umeshita, Koji;
Doki, Yuichiro;
Mori, Masaki;
Nagano, Hiroaki

Publication type:

Journal Article

Phase 1 study of N(1),N(11)diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma.

Published in:

2013

By:

Goyal, Lipika;
Supko, Jeffrey G;
Berlin, Jordan;
Blaszkowsky, Lawrence S;
Carpenter, Amanda;
Heuman, Douglas M;
Hilderbrand, Sarah L;
Stuart, Keith E;
Cotler, Scott;
Senzer, Neil N;
Chan, Emily;
Berg, Carl L;
Clark, Jeffrey W;
Hezel, Aram F;
Ryan, David P;
Zhu, Andrew X

Publication type:

Journal Article

Phase II trial of erlotinib in patients with advanced nonsmallcell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics.

Published in:

2013

By:

Motoshima, Kohei;
Nakamura, Yoichi;
Sano, Kazumi;
Ikegami, Yoji;
Ikeda, Takaya;
Mizoguchi, Kosuke;
Takemoto, Shinnosuke;
Fukuda, Minoru;
Nagashima, Seiji;
Iida, Tetsuya;
Tsukamoto, Kazuhiro;
Kohno, Shigeru

Publication type:

Journal Article

Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2‑positive breast cancer: an NSABP Foundation Research Program phase I study.

Published in:

2013

By:

Jankowitz, Rachel C;
Abraham, Jame;
Tan, Antoinette R;
Limentani, Steven A;
Tierno, Marni B;
Adamson, Laura M;
Buyse, Marc;
Wolmark, Norman;
Jacobs, Samuel A

Publication type:

journal article

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double‑blind, placebo‑controlled trial of goshajinkigan to prevent oxaliplatin‑induced neuropathy.

Published in:

2013

By:

Kono, Toru;
Hata, Taishi;
Morita, Satoshi;
Munemoto, Yoshinori;
Matsui, Takanori;
Kojima, Hiroshi;
Takemoto, Hiroyoshi;
Fukunaga, Mutsumi;
Nagata, Naoki;
Shimada, Mitsuo;
Sakamoto, Junichi;
Mishima, Hideyuki

Publication type:

journal article

A retrospective analysis of early CA199 change in salvage chemotherapy for refractory pancreatic cancer.

Published in:

2013

By:

Nakai, Yousuke;
Isayama, Hiroyuki;
Sasaki, Takashi;
Takahara, Naminatsu;
Hamada, Tsuyoshi;
Uchino, Rie;
Mizuno, Suguru;
Miyabayashi, Koji;
Yamamoto, Keisuke;
Mohri, Dai;
Kogure, Hirofumi;
Yamamoto, Natsuyo;
Hirano, Kenji;
Ijichi, Hideaki;
Tateishi, Keisuke;
Tada, Minoru;
Koike, Kazuhiko

Publication type:

Journal Article

The role of antioxidants in the era of cardio‑oncology.

Published in:

2013

By:

Vincent, Duncan T;
Ibrahim, Yasmine F;
Espey, Michael Graham;
Suzuki, Yuichiro J

Publication type:

journal article

A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours.

Published in:

2013

By:

Horsley, Laura;
Cummings, Jeff;
Middleton, Mark;
Ward, Tim;
Backen, Alison;
Clamp, Andrew;
Dawson, Martin;
Farmer, Hayley;
Fisher, Nita;
Halbert, Gavin;
Halford, Sarah;
Harris, Adrian;
Hasan, Jurjees;
Hogg, Philip;
Kumaran, Gireesh;
Little, Ross;
Parker, Geoff J M;
Potter, Paula;
Saunders, Mark;
Roberts, Caleb

Publication type:

Journal Article

(13)C-uracil breath test to predict 5-fluorouracil toxicity in gastrointestinal cancer patients.

Published in:

2013

By:

Cunha-Junior, Geraldo Felício;
De Marco, Luiz;
Bastos-Rodrigues, Luciana;
Bolina, Marina Borges;
Martins, Flavia Linhares;
Pianetti, Gerson Antonio;
Cesar, Isabela Costa;
Coelho, Luiz Gonzaga

Publication type:

Journal Article

Angiotensin-(1-7) synergizes with colony-stimulating factors in hematopoietic recovery.

Published in:

2013

By:

Rodgers, Kathleen E;
Espinoza, Theresa B;
Roda, Norma;
Meeks, Christopher J;
Dizerega, Gere S

Publication type:

journal article

Investigation into CYP3A4-mediated drug-drug interactions on midostaurin in healthy volunteers.

Published in:

2013

By:

Dutreix, Catherine;
Munarini, Florence;
Lorenzo, Sebastien;
Roesel, Johannes;
Wang, Yanfeng

Publication type:

journal article

Investigation into CYP3A4-mediated drug–drug interactions on midostaurin in healthy volunteers.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1223, doi. 10.1007/s00280-013-2287-6

By:

Dutreix, Catherine;
Munarini, Florence;
Lorenzo, Sebastien;
Roesel, Johannes;
Wang, Yanfeng

Publication type:

Article

A novel antitumor piperazine alkyl compound causes apoptosis by inducing RhoB expression via ROS-mediated c-Abl/p38 MAPK signaling.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1315, doi. 10.1007/s00280-013-2310-y

By:

Chung, Kyung-Sook;
Han, Gyoonhee;
Kim, Bo-Kyung;
Kim, Hwan-Mook;
Yang, Jee Sun;
Ahn, Jiwon;
Lee, Kyeong;
Song, Kyung-Bin;
Won, Misun

Publication type:

Article

Transient severe hyperbilirubinemia after hepatic arterial infusion of oxaliplatin in patients with liver metastases.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1265, doi. 10.1007/s00280-013-2302-y

By:

Garcia, Sean S.;
Atkins, Johnique T.;
Falchook, Gerald S.;
Tsimberidou, Apostolia M.;
Hong, David S.;
Trivedi, Meghana V.;
Kurzrock, Razelle

Publication type:

Article

Erratum to: Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments.

Published in:

2013

By:

Pauley, Jennifer L.;
Panetta, John C.;
Crews, Kristine R.;
Pei, Deqing;
Cheng, Cheng;
McCormick, John;
Howard, Scott C.;
Sandlund, John T.;
Jeha, Sima;
Ribeiro, Raul;
Rubnitz, Jeffrey;
Pui, Ching-Hon;
Evans, William E.;
Relling, Mary V.

Publication type:

Correction Notice

The VEGF pathway in lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1169, doi. 10.1007/s00280-013-2298-3

By:

Alevizakos, Michalis;
Kaltsas, Serafim;
Syrigos, Konstantinos N.

Publication type:

Article

Differential regulation of sunitinib targets predicts its tumor-type-specific effect on endothelial and/or tumor cell apoptosis.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1183, doi. 10.1007/s00280-013-2300-0

By:

Bousquet, Guilhem;
Varna, Mariana;
Ferreira, Irmine;
Wang, Li;
Mongiat-Artus, Pierre;
Leboeuf, Christophe;
de Bazelaire, Cédric;
Faivre, Sandrine;
Bertheau, Philippe;
Raymond, Eric;
Germain, Stéphane;
Janin, Anne

Publication type:

Article

Phase II, open-label trial to assess QTcF effects, pharmacokinetics and antitumor activity of afatinib in patients with relapsed or refractory solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1213, doi. 10.1007/s00280-013-2286-7

By:

Molife, L. Rhoda;
Rudman, Sarah M.;
Alam, Salma;
Tan, Daniel S.-W.;
Kristeleit, Hartmut;
Middleton, Gary;
Propper, David;
Bent, Liz;
Stopfer, Peter;
Uttenreuther-Fischer, Martina;
Wallenstein, Gudrun;
de Bono, Johann;
Spicer, James

Publication type:

Article

An appraisal of subcutaneous trastuzumab: a new formulation meeting clinical needs.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1361, doi. 10.1007/s00280-013-2289-4

By:

Launay-Vacher, Vincent

Publication type:

Article

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1283, doi. 10.1007/s00280-013-2306-7

By:

Kono, Toru;
Hata, Taishi;
Morita, Satoshi;
Munemoto, Yoshinori;
Matsui, Takanori;
Kojima, Hiroshi;
Takemoto, Hiroyoshi;
Fukunaga, Mutsumi;
Nagata, Naoki;
Shimada, Mitsuo;
Sakamoto, Junichi;
Mishima, Hideyuki

Publication type:

Article

The role of antioxidants in the era of cardio-oncology.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1157, doi. 10.1007/s00280-013-2260-4

By:

Vincent, Duncan T.;
Ibrahim, Yasmine F.;
Espey, Michael Graham;
Suzuki, Yuichiro J.

Publication type:

Article

13C-uracil breath test to predict 5-fluorouracil toxicity in gastrointestinal cancer patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1273, doi. 10.1007/s00280-013-2309-4

By:

Cunha-Junior, Geraldo Felício;
De Marco, Luiz;
Bastos-Rodrigues, Luciana;
Bolina, Marina Borges;
Martins, Flavia Linhares;
Pianetti, Gerson Antonio;
Cesar, Isabela Costa;
Coelho, Luiz Gonzaga

Publication type:

Article

Phase II trial of erlotinib in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1299, doi. 10.1007/s00280-013-2307-6

By:

Motoshima, Kohei;
Nakamura, Yoichi;
Sano, Kazumi;
Ikegami, Yoji;
Ikeda, Takaya;
Mizoguchi, Kosuke;
Takemoto, Shinnosuke;
Fukuda, Minoru;
Nagashima, Seiji;
Iida, Tetsuya;
Tsukamoto, Kazuhiro;
Kohno, Shigeru

Publication type:

Article

Angiotensin-(1–7) synergizes with colony-stimulating factors in hematopoietic recovery.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1235, doi. 10.1007/s00280-013-2312-9

By:

Rodgers, Kathleen E.;
Espinoza, Theresa B.;
Roda, Norma;
Meeks, Christopher J.;
diZerega, Gere S.

Publication type:

Article

A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours.

Published in:

2013

By:

Horsley, Laura;
Cummings, Jeff;
Middleton, Mark;
Ward, Tim;
Backen, Alison;
Clamp, Andrew;
Dawson, Martin;
Farmer, Hayley;
Fisher, Nita;
Halbert, Gavin;
Halford, Sarah;
Harris, Adrian;
Hasan, Jurjees;
Hogg, Philip;
Kumaran, Gireesh;
Little, Ross;
Parker, Geoff J. M.;
Potter, Paula;
Saunders, Mark;
Roberts, Caleb

Publication type:

Report

Preclinical pharmacokinetic/pharmacodynamic/efficacy relationships for alisertib, an investigational small-molecule inhibitor of Aurora A kinase.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1255, doi. 10.1007/s00280-013-2305-8

By:

Palani, Santhosh;
Patel, Mayankbhai;
Huck, Jessica;
Zhang, Mengkun;
Balani, Suresh K.;
Yang, Johnny;
Chen, Susan;
Mettetal, Jerome;
Manfredi, Mark;
Shyu, Wen Chyi;
Ecsedy, Jeffrey A.;
Chakravarty, Arijit

Publication type:

Article

Flow cytometric chemosensitivity assay using JC-1, a sensor of mitochondrial transmembrane potential, in acute leukemia.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1335, doi. 10.1007/s00280-013-2303-x

By:

Yokosuka, Tomoko;
Goto, Hiroaki;
Fujii, Hisaki;
Naruto, Takuya;
Takeuchi, Masanobu;
Tanoshima, Reo;
Kato, Hiromi;
Yanagimachi, Masakatsu;
Kajiwara, Ryosuke;
Yokota, Shumpei

Publication type:

Article

Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2-positive breast cancer: an NSABP Foundation Research Program phase I study.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1205, doi. 10.1007/s00280-013-2262-2

By:

Jankowitz, Rachel C.;
Abraham, Jame;
Tan, Antoinette R.;
Limentani, Steven A.;
Tierno, Marni B.;
Adamson, Laura M.;
Buyse, Marc;
Wolmark, Norman;
Jacobs, Samuel A.

Publication type:

Article

Phase II study of concurrent thoracic radiotherapy in combination with weekly paclitaxel plus carboplatin in locally advanced non-small cell lung cancer: LOGIK0401.

Published in:

2013

By:

Takayama, Koichi;
Inoue, Koji;
Tokunaga, Shoji;
Matsumoto, Takemasa;
Oshima, Tsukasa;
Kawasaki, Masayuki;
Imanaga, Tomotoshi;
Kuba, Mutsuo;
Takeshita, Masafumi;
Harada, Taishi;
Shioyama, Yoshiyuki;
Nakanishi, Yoichi

Publication type:

Report

Phase 1 study of N1,N11-diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1305, doi. 10.1007/s00280-013-2293-8

By:

Goyal, Lipika;
Supko, Jeffrey G.;
Berlin, Jordan;
Blaszkowsky, Lawrence S.;
Carpenter, Amanda;
Heuman, Douglas M.;
Hilderbrand, Sarah L.;
Stuart, Keith E.;
Cotler, Scott;
Senzer, Neil N.;
Chan, Emily;
Berg, Carl L.;
Clark, Jeffrey W.;
Hezel, Aram F.;
Ryan, David P.;
Zhu, Andrew X.

Publication type:

Article

Pharmacokinetics of high-dose simvastatin in refractory and relapsed chronic lymphocytic leukemia patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1369, doi. 10.1007/s00280-013-2326-3

By:

Ahmed, Tamer A.;
Hayslip, John;
Leggas, Markos

Publication type:

Article

A retrospective analysis of early CA19-9 change in salvage chemotherapy for refractory pancreatic cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1291, doi. 10.1007/s00280-013-2313-8

By:

Nakai, Yousuke;
Isayama, Hiroyuki;
Sasaki, Takashi;
Takahara, Naminatsu;
Hamada, Tsuyoshi;
Uchino, Rie;
Mizuno, Suguru;
Miyabayashi, Koji;
Yamamoto, Keisuke;
Mohri, Dai;
Kogure, Hirofumi;
Yamamoto, Natsuyo;
Hirano, Kenji;
Ijichi, Hideaki;
Tateishi, Keisuke;
Tada, Minoru;
Koike, Kazuhiko

Publication type:

Article

Evaluation of safety parameters and changes in serum concentration in liver transplant recipients treated with doxorubicin during the anhepatic period.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1325, doi. 10.1007/s00280-013-2311-x

By:

Kobayashi, Shogo;
Wada, Hiroshi;
Hama, Naoki;
Akita, Hirofumi;
Kawamoto, Koichi;
Eguchi, Hidetoshi;
Umeshita, Koji;
Doki, Yuichiro;
Mori, Masaki;
Nagano, Hiroaki

Publication type:

Article

A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1247, doi. 10.1007/s00280-013-2308-5

By:

Oh, In-Jae;
Kim, Kyu-Sik;
Kim, Young-Chul;
Ban, Hee-Jung;
Kwon, Yong-Soo;
Kim, Yu-Il;
Lim, Sung-Chul;
Chung, Woong-Ki;
Nam, Taek-Keun;
Song, Joo-Young;
Yoon, Mee-Sun;
Ahn, Sung-Ja

Publication type:

Article

Effects of the aldehyde dehydrogenase inhibitor disulfiram on the plasma pharmacokinetics, metabolism, and toxicity of benzaldehyde dimethane sulfonate (NSC281612, DMS612, BEN) in mice.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1195, doi. 10.1007/s00280-013-2296-5

By:

Parise, Robert A.;
Beumer, Jan H.;
Clausen, Dana M.;
Rigatti, Lora H.;
Ziegler, Judy A.;
Gasparetto, Maura;
Smith, Clayton A.;
Eiseman, Julie L.

Publication type:

Article

Works matching IS 0344-5704 AND VI 72 AND IP 6 AND DT 2013

Flow cytometric chemosensitivity assay using JC1, a sensor of mitochondrial transmembrane potential, in acute leukemia.

Evaluation of safety parameters and changes in serum concentration in liver transplant recipients treated with doxorubicin during the anhepatic period.

Phase 1 study of N(1),N(11)diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma.

Phase II trial of erlotinib in patients with advanced nonsmallcell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics.

Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2‑positive breast cancer: an NSABP Foundation Research Program phase I study.

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double‑blind, placebo‑controlled trial of goshajinkigan to prevent oxaliplatin‑induced neuropathy.

A retrospective analysis of early CA199 change in salvage chemotherapy for refractory pancreatic cancer.

The role of antioxidants in the era of cardio‑oncology.

A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours.

(13)C-uracil breath test to predict 5-fluorouracil toxicity in gastrointestinal cancer patients.

Angiotensin-(1-7) synergizes with colony-stimulating factors in hematopoietic recovery.

Investigation into CYP3A4-mediated drug-drug interactions on midostaurin in healthy volunteers.

Investigation into CYP3A4-mediated drug–drug interactions on midostaurin in healthy volunteers.

A novel antitumor piperazine alkyl compound causes apoptosis by inducing RhoB expression via ROS-mediated c-Abl/p38 MAPK signaling.

Transient severe hyperbilirubinemia after hepatic arterial infusion of oxaliplatin in patients with liver metastases.

Erratum to: Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments.

The VEGF pathway in lung cancer.

Differential regulation of sunitinib targets predicts its tumor-type-specific effect on endothelial and/or tumor cell apoptosis.

Phase II, open-label trial to assess QTcF effects, pharmacokinetics and antitumor activity of afatinib in patients with relapsed or refractory solid tumors.

An appraisal of subcutaneous trastuzumab: a new formulation meeting clinical needs.

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy.

The role of antioxidants in the era of cardio-oncology.

<sup>13</sup>C-uracil breath test to predict 5-fluorouracil toxicity in gastrointestinal cancer patients.

Phase II trial of erlotinib in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics.

Angiotensin-(1–7) synergizes with colony-stimulating factors in hematopoietic recovery.

A phase 1 trial of intravenous 4-(<i>N</i>-(<i>S</i>-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours.

Preclinical pharmacokinetic/pharmacodynamic/efficacy relationships for alisertib, an investigational small-molecule inhibitor of Aurora A kinase.

Flow cytometric chemosensitivity assay using JC-1, a sensor of mitochondrial transmembrane potential, in acute leukemia.

Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2-positive breast cancer: an NSABP Foundation Research Program phase I study.

Phase II study of concurrent thoracic radiotherapy in combination with weekly paclitaxel plus carboplatin in locally advanced non-small cell lung cancer: LOGIK0401.

Phase 1 study of <i>N</i><sup>1</sup>,<i>N</i><sup>11</sup>-diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma.

Pharmacokinetics of high-dose simvastatin in refractory and relapsed chronic lymphocytic leukemia patients.

A retrospective analysis of early CA19-9 change in salvage chemotherapy for refractory pancreatic cancer.

Evaluation of safety parameters and changes in serum concentration in liver transplant recipients treated with doxorubicin during the anhepatic period.

A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401.

Effects of the aldehyde dehydrogenase inhibitor disulfiram on the plasma pharmacokinetics, metabolism, and toxicity of benzaldehyde dimethane sulfonate (NSC281612, DMS612, BEN) in mice.